SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 22, 2004
RESPIRONICS, INC.
(Exact name of Registrant as specified in its charter)
| Delaware | 000-16723 | 25-1304989 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
| 1010 Murry Ridge Lane Murrysville, Pennsylvania |
15668-8525 | |
| (Address of Principal Executive Offices) |
(Zip Code) |
| 724-387-5200 | ||
| (Registrant’s telephone number, including area code) |
| Item 9. REGULATION FD DISCLOSURE. | ||||||||
| SIGNATURES | ||||||||
| INDEX TO EXHIBITS | ||||||||
| Press Release | ||||||||
Item 9. REGULATION FD DISCLOSURE.
The following information is furnished pursuant to Item 12, “Disclosure of Results of Operations and Financial Condition.”
On January 22, 2004, Respironics Inc. issued a press release announcing its financial results for the three and six months ended December 31, 2003. A copy of the press release is attached hereto as Exhibit 99.
Exhibits
| 99 | Press release, dated January 22, 2004, issued by Respironics, Inc. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| RESPIRONICS, INC. By: /s/ Daniel J. Bevevino Daniel J. Bevevino Vice President, and Chief Financial and Principal Accounting Officer |
Dated: January 22, 2004
3
INDEX TO EXHIBITS
| Exhibit No. | Description | |
99 |
Press release, dated January 22, 2004, issued by Respironics, Inc. |
4